Sykon Capital LLC Pro Phase Labs, Inc. Put Options Transaction History
Sykon Capital LLC
- $300 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PRPH
# of Institutions
24Shares Held
2.16MCall Options Held
13.7KPut Options Held
0-
Susquehanna International Group, LLP Bala Cynwyd, PA398KShares$119,3740.0% of portfolio
-
Geode Capital Management, LLC Boston, MA303KShares$90,8780.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL237KShares$71,2010.0% of portfolio
-
Apollon Wealth Management, LLC Mount Pleasant, SC182KShares$54,7390.0% of portfolio
-
Black Rock Inc. New York, NY64.3KShares$19,2890.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $4.81M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...